Have a personal or library account? Click to login
Serum Levels of Thyroid Hormones and Thyroid Peroxidase Antibodies in Different Types of Glaucoma Cover

Serum Levels of Thyroid Hormones and Thyroid Peroxidase Antibodies in Different Types of Glaucoma

Open Access
|Jan 2025

References

  1. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121, 2081–2090. DOI: 10.1016/j.ophtha.2014.05.013.
  2. Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, et al. Primary open-angle glaucoma. Nat Rev Dis Primers. 2016; 2, 160–167. DOI: 10.1038/nrdp.2016.67.
  3. Miglior S, Bertuzzi F. Exfoliative glaucoma: new evidence in the pathogenesis and treatment. Prog Brain Res. 2015; 221, 233–241. DOI: 10.1016/bs.pbr.2015.06.007.
  4. Yumori JW, Cadogan MP. Primary open-angle glaucoma: clinical update. J Gerontol Nurs. 2011; 37(3), 10–15. DOI: 10.3928/00989134-20110210-01.
  5. Janssen SF, Gorgels TGMF, Ramdas WD. The vast complexity of primary open angle glaucoma: disease genes, risks, molecular mechanisms and pathobiology. Progress in Retinal and Eye Research. 2013; 37, 31–67. DOI: 10.1016/j.preteyeres.2013.09.001.
  6. Myer C, Abdelrahman L, Banerjee S, Khattri RB, Merritt ME, Junk AK. Aqueous humor metabolite profile of pseudoexfoliation glaucoma is distinctive. Molecular Omics. 2020; 16(5), 425–435. DOI: 10.1039/C9MO00192A.
  7. Sarenac-Vulovic T, Janicijevic-Petrovic M, Vulovic D, Pavlovic S, Simovic S, Zdravkovic N. Systemic manifestations of pseudoexfoliation. Ser J Exp Clin Res. 2014; 15(1), 29–32. DOI: 10.2478/SJECR-2014-0004.
  8. Rasmussen CA, Kaufman PL. The trabecular meshwork in normal eyes and in exfoliation glaucoma. J Glaucoma. 2014; 23, S15–9. DOI: 10.1097/IJG.0000000000000106.
  9. Schlötzer-Schrehardt U. New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?. 2012; 109(10), 944–951. DOI: 10.1007/s00347-012-2531-1.
  10. Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Survey of Ophthalmology. 2001; 45(4), 265–315. DOI: 10.1016/s0039-6257(00)00196-x.
  11. Palko JR, Qi O, Sheybani A. Corneal alterations associated with pseudoexfoliation syndrome and glaucoma: A literature review. J. Ophthalmic Vis.Res. 2017; 12(3), 312–324. DOI: 10.4103/jovr.jovr_28_17.
  12. Cockerham KP, Pal C, Jani B, Wolter A, Kennerdell JS. The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy. Ophthalmology. 1997; 104(6), 914–917. DOI: 10.1016/s0161-6420(97)30207-3.
  13. Smith KD, Arthurs BP, Saheb N. An association between hypothyroidism and primary open-angle glaucoma. Ophthalmology. 1993; 100(10), 1580–1584. DOI: 10.1016/s0161-6420(93)31441-7.
  14. Manor RS, Kurz O, Lewitus Z. Intraocular pressure in endocrinological patients with exophthalmos. Ophthalmologica. 1974; 168(4), 241–252. DOI: 10.1159/000307046.
  15. Smith KD, Tevaarwerk GJ, Allen LH. An ocular dynamic study supporting the hypothesis that hypothyroidism is a treatable cause of secondary openangle glaucoma. Can J Ophthalmol. 1992; 27(7), 341–344.
  16. Karadimas P, Bouzas EA, Topouzis F, Koutras DA, Mastorakos G. Hypothyroidism and glaucoma. A study of 100 hypothyroid patients. Am J Ophthalmol. 2011; 131, 126–128. DOI: 10.1016/s0002-9394(00)00724-8.
  17. Lin HC, Kang JH, Jiang YD, Ho JD. Hypothyroidism and the risk of developing open-angle glaucoma: a fiveyear population based follow-up study. Ophthalmology. 2010; 117, 1960–1966. DOI: 10.1016/j.ophtha.2010.02.005.
  18. Wang S, Liu Y, Zheng G. Hypothyroidism as a risk factor for open angle glaucoma: A systematic review and meta-analysis. PloS one. 2017; 12(10), e0186634. DOI: 10.1371/journal.pone.0186634.
  19. Kakigi C, Kasuga T, Wang SY, Singh K, Hiratsuka Y, Murakami A, et al. Hypothyroidism and Glaucoma in The United States. PloS one. 2015; 10(7), e0133688. DOI: 10.1371/journal.pone.0133688.
  20. Motsko SP, Jones JK. Is there an association between hypothyroidism and open-angle glaucoma in an elderly population? An epidemiologic study. Ophthalmology. 2008; 115(9), 1581–1584. DOI: 10.1016/j.ophtha.2008.01.016.
  21. Cheng H, Perkins ES. Thyroid disease and glaucoma. Br J Ophthalmol. 1967; 51(8), 547–553. DOI: 10.1136/bjo.51.8.547.
  22. Duncan KG, Jumper MD, Ribeiro RC, et al. Human trabecular meshwork cells as a thyroid hormone target tissue: presence of functional thyroid hormone receptors. Graefes Arch Clin Exp Ophthalmol. 1999; 237(3), 231–240. DOI: 10.1007/s004170050224.
  23. Bahceci UA, Ozdek S, Pehlivanli Z, Yetkin I, Onol M. Changes in intraocular pressure and corneal and retinal nerve fiber layer thicknesses in hypothyroidism. Eur J Ophthalmol. 2005; 15(5), 556–561. DOI: 10.5301/EJO.2008.1004.
  24. Stein R, Romano A, Treister G, Bartov E. Effect of subconjunctival injection of hyaluronidase on outflow resistance in normal and in open-angle glaucomatous patients. Metab Pediatr Syst Ophthalmol. 1982; 6, 169–174.
  25. Gartaganis SP, Georgakopoulos CD, Exarchou AM, et al. Increased aqueous humor basic fibroblast growth factor and hyaluronan levels in relation to the exfoliation syndrome and exfoliative glaucoma. Acta Ophthalmol Scand. 2001; 79(6), 572–575.
  26. Gao C, Li T, Liu J, Guo Q, Tian L. Endothelial functioning and hemodynamic parameters in rats with subclinical hypothyroid and the effects of thyroxine replacement. PloS one. 2015; 10(7), e0131776. DOI: 10.1371/journal.pone.0131776.
  27. Wax MB. Is there a role for the immune system in glaucomatous optic neuropathy? Curr Opin Ophthalmol. 2000; 11(2), 145–150. DOI: 10.1097/00055735-200004000-00014.
  28. Cartwright MJ, Grajewski AL, Friedberg ML, Anderson DR, Richards DW. Immune-related disease and normal-tension glaucoma. A case–control study. Arch Ophthalmol. 1992; 110(4), 500–502. DOI: 10.1001/archopht.1992.01080160078035.
  29. Wax MB, Tezel G, Saito I, et al. Anti-Ro/SS-A positivity and heat shock antibodies in patients with normal-pressure glaucoma. Am I Ophthalmol. 1998; 125(2), 145–157. DOI: 10.1016/s0002-9394(99)80084-1.
  30. Maruyama I, Ohguro H, Ikeda Y. Retinal ganglion cells recognized by serum autoantibody against gammaenolase found in glaucoma patients. Invest Ophthalmol Vis Sci. 2000; 41(7), 1657–1665.
  31. Yang J, Tezel G, Patil RV, Romano C, Wax MB. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmol Vis Sci. 2001; 42(6), 1273–1276.
  32. Kremmer S, Kreuzfelder E, Klein R, Bontke N, Henneberg-Quester KB, Steuhl KP, GrosseWilde H. Antiphosphatidylserine antibodies are elevated in normal-tension glaucoma. Clin Exp Immunol. 2001; 125(2), 211–215. DOI: 10.1046/j.1365-2249.2001.01578.x.
  33. Ikeda Y, Maruyama I, Nakazawa M, Ohguro H. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol. 2002; 46(1), 13–17. DOI: 10.1016/s0021-5155(01)00455-5.
DOI: https://doi.org/10.2478/eabr-2024-0025 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Submitted on: May 7, 2024
Accepted on: May 31, 2024
Published on: Jan 30, 2025
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Katarina Cupic, Jovana Srejovic, Suncica Sreckovic, Nenad Petrovic, Dusan Todorovic, Kristina Dugalic, Rasa Mladenovic, Miroslav Stamenkovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT